Abstract
We describe an unusual case of a thoracic aortic aneurysm caused byAspergillus. A 70-year-old man underwent prednisolone and Ara-C treatments for a myelodysplastic syndrome. Blood examination revealed pancytopenia. Under these treatments, an aneurysm presented at the distal aortic arch. He underwent resection of the aneurysm with a graft repair covered by a pedicled omentum flap, followed by prolonged administration of micafungin and itraconazole for a mycotic aneurysm. The postoperative course was favorable without complications. Serum C-reactive protein became negative and he was discharged 2 months after the surgery. However, 4 months after the surgery, he died from worsening of the myelodysplastic syndrome. The prognosis for patients with mycotic aneurysms is poor due to their immunocompetent condition arising from underlying diseases. Therefore, in addition to prompt treatment with antifungal agents combined with surgical debridement, control of the underlying disease is essential for improving the outcome. (Jpn J Thorac Cardiovasc Surg 2006; 54:160-163)
This is a preview of subscription content, log in via an institution to check access.
References
Wells WJ, Fox AH, Theodore PR, Ross LA, Stanley P, Starnes VA. Aspergillosis of the posterior mediastinum. Ann Thorac Surg 1994; 57: 1240–3.
Silva ME, Malogolowkin MH, Hall TR, Sadeghi AM, Krogstad P. Mycotic aneurysm of the thoracic aorta due to Aspergillus terreus: Case report and review. Clin Infect Dis 2000; 31:1144–8.
Hasegawa T, Tsukube T, Higuma T, Okita Y. Successful replacement of aortic root with valvesparing technique and proximal arch in a patient with myelodysplastic syndrome. Jpn J Thorac Cardiovasc Surg 2003; 51: 322–5.
Yoshida Y, Hirashima K, Asano S, Takaku F. A phase II trial of recombinant human granulocyte colony-stimulating factor in the myelodysplastic syndromes. Br J Haematol 1991; 78: 378–84.
McHenry MC, Rehm SJ, Krajewski LP, Duchesneau PM, Levin HS, Steinmuller DR. Vertebral osteomyelitis and aortic lesions: Case report and review. Rev Infect Dis l991;13: 1184–94.
Chan FY, Crawford ES, Coselli JS, Safi HJ, Williams TW Jr. In situ prosthetic graft replacement for mycotic aneurysm of the aorta. Ann Thorac Surg 1989; 47: 193–203.
Coselli JS, Crawford ES, Williams TW Jr, Bradshaw MW, Wiemer DR, Harris RL, et al. Treatment of postoperative infection of ascending aorta and transverse aortic arch, including use of viable omentum and muscle flaps. Ann Thorac Surg 1990; 50: 868–81.
Fromtling RA. Micafungin sodium (FK-463). Drugs Today 2002; 38: 245–57.
Yokote T, Akioka T, Oka S, Fujisaka T, Yamano T, Hara S, et al. Successful treatment with micafungin of invasive pulmonary aspergillosis in acute myeloid leukemia, with renal failure due to amphotericin B therapy. Ann Hematol 2004; 83: 64–6.
Denning DW, Lee JY, Hostetler JS, Pappas P, Kauffman CA, Dewsnup DH, et al. NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis. Am J Med 1994; 97: 135–44.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hosono, M., Hattori, K., Shibata, T. et al. Mycotic aneurysm of the distal aortic arch caused byAspergillus . Jpn J Thorac Caridovasc Surg 54, 160–163 (2006). https://doi.org/10.1007/BF02662471
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02662471